Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca announces first direct-to-patient program offering ARIMIDEX
The Fly on the Wall
Thursday, February 16, 2012 - 9:29am
tags:
Arimidex, AstraZeneca, Express Scripts
J&J to Develop Spider Venom Pain Drug With Queensland University
Bloomberg
Thursday, February 16, 2012 - 9:28am
tags:
JNJ, pain management, chronic pain
FDA biosimilars guidance sparks reviews of IP protection
Mass High Tech
Wednesday, February 15, 2012 - 1:35pm
tags:
FDA, biosimilars, intellectual property
Teva scrambling toward post-Copaxone future
Fierce Pharma
Wednesday, February 15, 2012 - 1:33pm
tags:
Teva Pharmaceuticals, Copaxone
BioCryst jumps on hepatitis C study
Marketwatch
Wednesday, February 15, 2012 - 1:31pm
tags:
Biocryst, hepatitis C, BCX5191
Bionor Rises Most in 15 Months on AIDS Drug Study
Bloomberg
Wednesday, February 15, 2012 - 1:30pm
tags:
Bionor Pharma, HIV
Incyte Shares Decline After Fourth-Quarter Earnings
Bloomberg
Wednesday, February 15, 2012 - 1:29pm
tags:
earnings, Incyte
Sun Pharma: Wyeth Claims Damages Of $960M In Protonix Case
WSJ Online
Wednesday, February 15, 2012 - 10:54am
tags:
Wyeth, Sun Pharma, Protonix, India
Corporate VCs crowd into $43M round for Celladon
Fierce Biotech
Wednesday, February 15, 2012 - 10:51am
tags:
venture capital, Celladon, Mydicar, heart failure
Dilemma: When 1 Drug Treats 2 Diseases
WSJ Online
Wednesday, February 15, 2012 - 10:50am
tags:
Novartis, Gilenya, ALS
Antibiotics no help against most sinus infections
Yahoo/Reuters
Wednesday, February 15, 2012 - 10:41am
tags:
antibiotics, antibiotic resistance, sinus infections
Glaxo Uses Mediation to Settle Almost 25,000 Avandia Diabetes-Drug Claims
Bloomberg
Wednesday, February 15, 2012 - 10:40am
tags:
Avandia, GSK, diabetes, settlements
Still Betting On Chelsea's Flagship Drug?
Seeking Alpha
Wednesday, February 15, 2012 - 10:37am
tags:
Chelsea Therapeutics, Northera
Drugmakers Seek Deals to Gain Share of Future Hepatitis C Combination Pill
Bloomberg
Wednesday, February 15, 2012 - 8:55am
tags:
M&A, Inhibitex, Indenix, hepatitis C, Bristol-Myers Squibb, Achillion
Teva Pharmaceutical 4Q profit tumbles 34 percent
Yahoo/AP
Wednesday, February 15, 2012 - 8:52am
tags:
Teva Pharmaceuticals, earnings
Merck strikes Brazil joint venture to sell medicines
Reuters
Wednesday, February 15, 2012 - 8:51am
tags:
Merck, Brazil, Supera Farma, Cristalia, Eurofarma
BioSante Gains on U.S. Approval of Testosterone Replacement
Bloomberg
Wednesday, February 15, 2012 - 8:49am
tags:
BioSante, Bio-T-Gel, testosterone
Zalicus Says Workforce Reduction Is A Strategic Decision
Seeking Alpha
Tuesday, February 14, 2012 - 5:02pm
tags:
Zalicus, layoffs, Novartis, Sanofi, Cubist Pharmaceuticals
J&J tries to ease EU concerns on Synthes buy
Reuters
Tuesday, February 14, 2012 - 4:55pm
tags:
JNJ, Synthes, Europe, M&A
5 High-Risk, High-Reward Biopharma Stocks
Seeking Alpha
Tuesday, February 14, 2012 - 11:30am
tags:
Arena Pharmaceuticals, Chelsea Therapeutics, BioLineRx, Keryx, Aeterna Zentaris

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.